Dendritic cells tagged posts

Nanotechnology used to Destroy and Prevent Relapse of Solid Tumor Cancers

 B7 co-stimulation enhances the anti-PD1-based immunosuppression reversal.

As people across the globe look forward to longer life expectancies, malignant cancers continue to pose threats to human health. The exploration and development of immunotherapy aims to seek new breakthroughs for the treatment of solid tumours.

The successful establishment of anti-tumour immunity requires the activation, expansion and differentiation of antigen-specific lymphocytes. This process largely depends on specific interactions between various T cells and antigen-presenting cells (APCs) in the body. However, existing tumour vaccines, such as neoantigen vaccines and various vector vaccines, all rely on random interactions with APCs in the body...

Read More

Memory Killer T cells are primed in the Spleen during Influenza infection

Illustration of a T lymphocyte, or T cell, white blood cells targeting SARS-CoV-2 coronavirus particles. T lymphocytes are components of the body's immune system. Helper T cells stimulate other immune cells to act against a pathogen, whereas killer T cells target and destroy infected cells themselves. SARS-CoV-2 emerged in Wuhan, China, in December 2019, and causes a mild respiratory illness (covid-19) that can develop into pneumonia and be fatal in some cases.
This finding upends the long-held paradigm that priming during lung infections takes place only in the draining lymph nodes, and it will be key to developing more efficient vaccinations and therapies for respiratory challenges.

CD8+ T cells – known as “killer” T cells – are the assassins of the immune system. Once they are primed, they seek out and destroy other cells that are infected with virus or cells that are cancerous.

Priming involves dendritic cells – sentinels of the immune system. In an influenza infection in the lungs, for example, lung-migratory dendritic cells capture a piece of the viral antigen, and then migrate out of the lung to the place where naïve T cells reside, to present that antigen to the CD8+ T cells. This primes the T cells to know which cells to attack.

...Read More

Unravelling the Secret of a Critical Immune Cell for Cancer Immunity

Tissue captured under a microscope
DC-SCRIPT positive cells (red) activating an
immune response (blue T cells)
Credit: Wang Cao and Shengbo Zhang

WEHI researchers have discovered a key differentiation process that provides an essential immune function in helping to control cancer and infectious diseases.

The research, published in Science Immunology, is the first to show a new factor — DC-SCRIPT — is required for the function a particular type of dendritic cell — called cDC1 — that is essential in controlling the immune response to infection.

Led by WEHI Professor Stephen Nutt, Dr Michael Chopin and Mr Shengbo Zhang, it defines the role for a new regulatory protein in producing dendritic cells...

Read More

How Allergens Trigger Itching: Finding points to new targets for allergy drug development

Figure thumbnail fx1
Substance P Release by Sensory Neurons Triggers Dendritic Cell Migration and Initiates the Type-2 Immune Response to AllergensImmunity, 2020; DOI: 10.1016/j.immuni.2020.10.001

A key step in the immune system’s response to allergens has been uncovered by researchers at Massachusetts General Hospital (MGH). They have shown that a neuropeptide called Substance P is released by certain neurons in the skin when they detect allergens, and that this substance is essential in the development of allergen-induced immune responses. This research could lead to the development of new and better methods to treat and prevent allergies.

How allergens are detected by the immune system had not been known...

Read More